Annual Cash & Cash Equivalents
$21.66 M
+$5.31 M+32.47%
31 December 2023
Summary:
Cardiff Oncology annual cash & cash equivalents is currently $21.66 million, with the most recent change of +$5.31 million (+32.47%) on 31 December 2023. During the last 3 years, it has fallen by -$109.33 million (-83.47%). CRDF annual cash & cash equivalents is now -83.47% below its all-time high of $130.98 million, reached on 31 December 2020.CRDF Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$13.04 M
-$12.46 M-48.87%
30 September 2024
Summary:
Cardiff Oncology quarterly cash and cash equivalents is currently $13.04 million, with the most recent change of -$12.46 million (-48.87%) on 30 September 2024. Over the past year, it has dropped by -$2.19 million (-14.41%). CRDF quarterly cash and cash equivalents is now -90.05% below its all-time high of $130.98 million, reached on 31 December 2020.CRDF Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.5% | -14.4% |
| 3 y3 years | -83.5% | -1.0% |
| 5 y5 years | +89.1% | +44.4% |
CRDF Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.5% | +81.3% | -48.9% | +9.2% |
| 5 y | 5 years | -83.5% | +112.4% | -90.0% | +44.4% |
| alltime | all time | -83.5% | >+9999.0% | -90.0% | +2121.9% |
Cardiff Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.04 M(-48.9%) |
| June 2024 | - | $25.50 M(+36.7%) |
| Mar 2024 | - | $18.66 M(-13.8%) |
| Dec 2023 | $21.66 M(+32.5%) | $21.66 M(+42.2%) |
| Sept 2023 | - | $15.23 M(-21.4%) |
| June 2023 | - | $19.37 M(+29.0%) |
| Mar 2023 | - | $15.02 M(-8.1%) |
| Dec 2022 | $16.35 M(+36.9%) | $16.35 M(-12.7%) |
| Sept 2022 | - | $18.72 M(-10.7%) |
| June 2022 | - | $20.96 M(+4.6%) |
| Mar 2022 | - | $20.05 M(+67.9%) |
| Dec 2021 | $11.94 M(-90.9%) | $11.94 M(-9.3%) |
| Sept 2021 | - | $13.16 M(+24.4%) |
| June 2021 | - | $10.58 M(-27.8%) |
| Mar 2021 | - | $14.66 M(-88.8%) |
| Dec 2020 | $130.98 M(+1184.7%) | $130.98 M(+259.8%) |
| Sept 2020 | - | $36.41 M(+31.2%) |
| June 2020 | - | $27.75 M(+199.2%) |
| Mar 2020 | - | $9.28 M(-9.0%) |
| Dec 2019 | $10.20 M(-11.0%) | $10.20 M(+12.9%) |
| Sept 2019 | - | $9.03 M(-16.3%) |
| June 2019 | - | $10.79 M(-4.8%) |
| Mar 2019 | - | $11.33 M(-1.1%) |
| Dec 2018 | $11.45 M | $11.45 M(-24.0%) |
| Sept 2018 | - | $15.07 M(-18.5%) |
| June 2018 | - | $18.49 M(+177.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $6.66 M(-19.1%) |
| Dec 2017 | $8.23 M(-40.9%) | $8.23 M(+10.6%) |
| Sept 2017 | - | $7.43 M(-4.5%) |
| June 2017 | - | $7.78 M(-23.6%) |
| Mar 2017 | - | $10.18 M(-26.8%) |
| Dec 2016 | $13.92 M(-79.4%) | $13.92 M(-38.3%) |
| Sept 2016 | - | $22.57 M(-0.0%) |
| June 2016 | - | $22.58 M(-62.4%) |
| Mar 2016 | - | $59.99 M(-11.1%) |
| Dec 2015 | $67.49 M(+147.3%) | $67.49 M(-9.0%) |
| Sept 2015 | - | $74.15 M(+79.6%) |
| June 2015 | - | $41.29 M(-6.1%) |
| Mar 2015 | - | $44.00 M(+61.2%) |
| Dec 2014 | $27.29 M(+5.6%) | $27.29 M(-12.4%) |
| Sept 2014 | - | $31.16 M(-10.1%) |
| June 2014 | - | $34.67 M(+51.6%) |
| Mar 2014 | - | $22.87 M(-11.5%) |
| Dec 2013 | $25.84 M(+138.8%) | $25.84 M(-7.1%) |
| Sept 2013 | - | $27.80 M(+234.8%) |
| June 2013 | - | $8.30 M(-9.4%) |
| Mar 2013 | - | $9.16 M(-15.3%) |
| Dec 2012 | $10.82 M(+1444.8%) | $10.82 M(+38.4%) |
| Sept 2012 | - | $7.82 M(-16.0%) |
| June 2012 | - | $9.30 M(+1485.6%) |
| Mar 2012 | - | $586.80 K(-16.2%) |
| Dec 2011 | $700.40 K(+1093.2%) | $700.40 K |
| Dec 2010 | $58.70 K | - |
FAQ
- What is Cardiff Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cardiff Oncology?
- What is Cardiff Oncology annual cash & cash equivalents year-on-year change?
- What is Cardiff Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cardiff Oncology?
- What is Cardiff Oncology quarterly cash and cash equivalents year-on-year change?
What is Cardiff Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of CRDF is $21.66 M
What is the all time high annual cash & cash equivalents for Cardiff Oncology?
Cardiff Oncology all-time high annual cash & cash equivalents is $130.98 M
What is Cardiff Oncology annual cash & cash equivalents year-on-year change?
Over the past year, CRDF annual cash & cash equivalents has changed by +$5.31 M (+32.47%)
What is Cardiff Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRDF is $13.04 M
What is the all time high quarterly cash and cash equivalents for Cardiff Oncology?
Cardiff Oncology all-time high quarterly cash and cash equivalents is $130.98 M
What is Cardiff Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, CRDF quarterly cash and cash equivalents has changed by -$2.19 M (-14.41%)